Clinical Trials Directory

Trials / Completed

CompletedNCT03718026

The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Multiple Sclerosis

The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test Test in Patients With Multiple Sclerosis

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
Gazi University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The aim of the study is to investigate reliability, validity, and responsiveness of the timed 360° turn test in patients with Multiple Sclerosis.

Detailed description

At baseline, the timed 360° turn test, Berg Balance Scale, Timed Up and Go test, Functional Reach Test, Four Square Step Test, and One-legged Stance Test is applied to the Multiple Sclerosis group. The timed 360° turn test is repeated after seven days from the first application in patients with Multiple Sclerosis. Healthy controls are going to perform only the timed 360° turn test.

Conditions

Interventions

TypeNameDescription
OTHERThe timed 360° turn test* The timed 360° turn test: Each participant turns around in place in a standing position for both sides. * Berg Balance Scale: It has 14 items, each of which is scored from 0 (i.e, severely impaired balance) to 4 (i.e., no balance impairment). * Timed Up and Go test: It requires individual to stand up from an armed chair, walk 3m, turn around, walk back to the armed chair, and sit down again. * Functional Reach Test: It measures the maximum distance an individual is able to reach forward beyond arm's length in the standing position when maintaining a fixed base of support. * One-leg stance test: Individuals were asked to stand on either their left or right leg. * Four square step test: It requires an individual to step over obstacles in various directions including forward, backward, and sideways.

Timeline

Start date
2018-10-24
Primary completion
2018-11-16
Completion
2018-11-19
First posted
2018-10-24
Last updated
2018-11-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03718026. Inclusion in this directory is not an endorsement.